UK-based Mogrify, a provider of internal cell therapy programs, has secured $16 million in funding. Ahren Innovation Capital led the round.
Source: Press Release
UK-based Mogrify, a provider of internal cell therapy programs, has secured $16 million in funding. Ahren Innovation Capital led the round.
Source: Press Release
Copyright PEI Media
Not for publication, email or dissemination
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.